Synthesis of galactopyranosyl amino alcohols as a new class of antitubercular and antifungal agents

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 2, 2004, Pages 329-332

  Tewari, Neetu ^a   Tiwari, V K ^a   Tripathi, R P ^a   Chaturvedi, V ^a   Srivastava, A ^a   Srivastava, R ^a   Shukla, P K ^a   Chaturvedi, A K ^a   Gaikwad, A ^a   Sinha, S ^a   Srivastava, B S ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOALCOHOL; ETHAMBUTOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SYNTHESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SCREENING;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0346099288     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.11.020     Document Type: Article

References (32)

1. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M. JAMA. 282:1999;677.
2. Rouhi A.M. Chem. Eng. News. 77:1999;51.
3. (a) Mendez A.P., Raviglione M.C., Laszlo A., Binkin N., Rieder H.L., Bustreo F., Cohn D.L., Lambregts-van Weezenbeek C.S., Kim S.J., Chaulet P., Nunn P. N. Engl. J. Med. 339:1998;139
4. (b) Mendez A.P., Raviglione M.C.etal. N. Engl. J. Med. 338:1998;1641.
5. (a) Viskum K., Kok-Jensen A. Int. J. Tuberc. Lung Dis. 1:1997;299
6. (b) Shafer R.W., Edlin B.R. Clin. Infect. Dis. 22:1996;683.
7. (a) Mitchison D.A. Int. J. Tuberc. Lung Dis. 2:1998;10
8. (b) Bastian I., Colebunders R. Drugs. 58:1999;633
9. (c) Telenti A., Iseman M. Drugs. 59:2000;171.
10. (a) Stephen G.H. Antimicrob. Agents Chemother. 46:2002;267, and references cited therein
11. (b) Dye C., Williams B.G., Espina M.A. Science. 295:2002;2042.
12. (a) Kruuner A., Sillastu H., Danilovitsh M., Levina K., Svenson S.B., Kallenius G., Haffner S.E. Int. J. Tuberc. Lung Dis. 2:1998;130
13. (b) Biava M., Porretta G.C., Deidda D., Pompei R., Tafi A., Manetti F. Bioorg. Med. Chem. 11:2003;515.
14. Brennan P.J., Nikaido H. Ann. Rev. Biochem. 64:1995;29.
15. Blanchard J.S. Ann. Rev. Biochem. 65:1996;215.
16. Daffe M., Etienne G. Tubercl. Lung Dis. 79:1999;153.
17. Belanger A.E., Besra G.S., Ford M.E., Mikusova K., Belisle J.T., Brennan P.J., Inamine J.M. Proc. Natl. Acad. Sci. U.S.A. 93:1996;11919.
18. Lee R.E., Mikusova K., Brennan P.J., Besra G.S. J. Am. Chem. Soc. 117:1995;11829.
19. Maddry J.A., Bansal N., Bermudez L.E., Comber R.N., Orme I.M., Suling W.J., Wilson L.N., Reynolds R.C. Bioorg. Med. Chem. Lett. 8:1998;237.
20. Tripathi R.P., Tripathi R., Tiwari V.K., Bala L., Sinha S., Srivastava R., Srivastava B.S. Eur. J. Med. Chem. 37:2002;773.
21. Tewari N., Mishra R.C., Tripathi R.P., Ahemad R., Srivastava A.K., Srivastava R., Srivastava B.S. Bioorg. Med. Chem. 11:2003;2911.
22. Kurita, H.; Yamaguschi, T. Eur. Pat. Appl. E. P. 650974, C. A. 123, 31439f, 1995.
23. Hopkins S.J. Drugs Future. 10:1985;301. (manufacture: Greenwich Pharma), and references cited therein.
24. (a) Gordon, P. Strategic Med. Res. Corp. US 3939 145, DE 240965. (b) Khan A.R., Tripathi R.P., Bhaduri A.P., Sahai R., Puri A., Tripathi L.M., Srivastava V.M.L. Eur. J. Med. Chem. 36:2001;435.
25. Tripathi R.P., Singh V., Khan A.R., Bhaduri A.P., Saxena G., Chandra K. Indian J. Chem. 34B:1995;791.
26. Rana N.S., Gupta P., Tripathi R.P., Bhaduri A.P. Acta Pharma. 51:2001;63.
27. Chittenden C.J.F. Carbohydr. Res. 15:1970;101.
28. 2).
29. 2).
30. Katiyar D., Tiwari V.K., Tripathi R.P., Srivastava A., Chaturvedi V., Srivastava R., Srivastava B.S. Bioorg. Med. Chem. 11:2003;4369.
31. National committee for clinical laboratory standards, 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Apporved standard document M 27-A. National committee for Clinical Laboratory Standards, Wayne, PA, USA.
32. National committee for clinical laboratory standards, 1998. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi: proposed standard. Document M 38-P. National Committee for Clinical Laboratory Standards, Wayne, PA, USA.